Ironwood Pharmaceuticals, Inc. (IRWD)
4.08
+0.11
(+2.77%)
USD |
NASDAQ |
Sep 11, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Price : 4.08 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 4.03 | 4.105 | 3.94 | 4.08 | 1.250M |
| Sep 10, 2026 | 4.03 | 4.05 | 3.94 | 3.97 | 1.174M |
| Sep 09, 2026 | 4.14 | 4.16 | 4.035 | 4.07 | 1.477M |
| Sep 08, 2026 | 4.25 | 4.27 | 4.075 | 4.17 | 2.276M |
| Sep 04, 2026 | 4.26 | 4.33 | 4.22 | 4.26 | 829291.0 |
| Sep 03, 2026 | 4.45 | 4.48 | 4.275 | 4.29 | 1.133M |
| Sep 02, 2026 | 4.31 | 4.475 | 4.26 | 4.41 | 2.432M |
| Sep 01, 2026 | 4.19 | 4.315 | 4.18 | 4.27 | 1.456M |
| Aug 31, 2026 | 4.13 | 4.26 | 4.015 | 4.25 | 1.670M |
| Aug 28, 2026 | 4.20 | 4.21 | 4.08 | 4.13 | 1.519M |
| Aug 27, 2026 | 4.24 | 4.30 | 4.15 | 4.24 | 961650.0 |
| Aug 26, 2026 | 4.38 | 4.38 | 4.235 | 4.29 | 1.029M |
| Aug 25, 2026 | 4.16 | 4.43 | 4.13 | 4.39 | 1.849M |
| Aug 24, 2026 | 4.26 | 4.28 | 4.12 | 4.13 | 1.384M |
| Aug 21, 2026 | 4.22 | 4.30 | 4.185 | 4.29 | 2.273M |
| Aug 20, 2026 | 4.255 | 4.29 | 4.045 | 4.14 | 1.471M |
| Aug 19, 2026 | 4.48 | 4.49 | 4.305 | 4.36 | 1.478M |
| Aug 18, 2026 | 4.345 | 4.40 | 4.26 | 4.31 | 1.411M |
| Aug 17, 2026 | 4.31 | 4.410 | 4.23 | 4.36 | 1.377M |
| Aug 14, 2026 | 4.03 | 4.35 | 3.96 | 4.31 | 2.334M |
| Aug 13, 2026 | 4.41 | 4.41 | 4.05 | 4.08 | 2.084M |
| Aug 12, 2026 | 4.32 | 4.505 | 4.255 | 4.32 | 2.721M |
| Aug 11, 2026 | 4.08 | 4.315 | 4.06 | 4.30 | 1.930M |
| Aug 10, 2026 | 4.17 | 4.275 | 4.04 | 4.05 | 2.184M |
| Aug 07, 2026 | 4.30 | 4.40 | 4.21 | 4.32 | 1.843M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Rigel Pharmaceuticals, Inc. | 47.24 |
| Marker Therapeutics, Inc. | 1.15 |
| Theriva Biologics, Inc. | 0.2476 |
| AbbVie, Inc. | 257.12 |
| Capricor Therapeutics, Inc. | 8.37 |
Price Related Metrics
| PE Ratio | 5.321 |
| PS Ratio | 1.766 |
| Price to Free Cash Flow | 3.705 |
| Earnings Yield | 18.79% |
| Market Cap | 674.18M |
| Operating PE Ratio | 2.912 |
| Normalized PE Ratio | 5.27 |